Orally administered sutezolid is rapidly oxidized in vivo to an active sulfoxide metabolite (PNU-101603), which then undergoes renal excretion.
Products > Drug Discovery > Inhibitor > Other Inhibitors | Products > Drug Discovery > Inhibitor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye